Table 1 Baseline characteristics of study participants in relation to the presence of Non-alcoholic fatty liver disease (N = 181)

Sex

0.57

 Male

54 (29.8)

18 (32.7)

36 (28.6)

 Female

127 (70.2)

37 (67.3)

90 (71.4)

Age (years): < 30

1 (0.5)

1 (1.8)

0

α

 30–40

16 (8.8)

3 (5.4)

13 (10.3)

0.29

 41–50

30 (16.5)

6 (10.9)

24 (19.0)

0.18

 51–60

55 (30.4)

20 (36.3)

35 (27.8)

0.25

 61–70

58 (32.0)

21 (38.2)

37 (29.4)

0.24

  > 70

21 (11.6)

4 (7.3)

17 (13.5)

0.23

BMI (kg/m²): Overweight (25–29.9)

31 (17.1)

6 (10.9)

25 (19.8)

0.14

 Obesity class I (30 to 34.9)

76 (41.9)

18 (32.7)

58 (46.0)

0.09

 Obesity class II (35–39.9)

50 (27.6)

19 (34.6)

31 (24.6)

0.17

 Obesity class III (≥40)

24 (13.3)

12 (21.8)

12 (9.5)

0.03

Residence

0.12

 Urban

93 (52.4)

33 (60.0)

60 (47.6)

 Rural

88 (48.6)

22 (40.0)

66 (52.4)

Underlying condition

 Hypertension

131 (72.4)

44 (80.0)

87 (69.0)

0.13

 Diabetes Mellitus

80 (44.2)

30 (54.5)

50 (39.7)

0.06

 Hypertension and diabetes mellitus

74 (40.9)

28 (50.9)

46 (36.5)

0.07

Systolic blood pressure (mmHg)

134 (122–146)

141 (126–153)

13 3 (121–143)

0.05

Diastolic blood pressure (mmHg)

83 (73–89)

86 (74–90)

81.5 (72.0–88.0)

0.16

Waist circumference (cm)

103.5 (98–113.5)

109 (99–121)

102 (97–112)

0.006

Triglycerides (mg/dl)

1.4 (1.0–1.9)

1.9 (1.2–2.3)

1.2 (0.9–1.6)

< 0.001

High-density lipoproteins (mmol/L)

1.1 (0.9–1.4)

1.0 (0.8–1.3)

1.1 (0.9–1.4)

0.03

Fasting blood glucose (mmol/L)

5.8 (5.2–6.8)

6.4 (5.6–7.9)

5.6 (5.2–6.3)

< 0.001

Uric acid (μmol/L)

381.4 (310.6–447.8)

426 (335.7–532.0)

372.4 (295.8–423.1)

< 0.001

Triglyceride-glucose index

8.8 (8.4–9.2)

9.2 (8.8–9.5)

8.6 (8.4–8.9)

< 0.001

Triglyceride-glucose index-BMI

293.4 (268.6–324.7)

320.2 (289.1–354.6)

286.4 (266.1–312.3)

< 0.001